Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection Images
Generic Name: lenacapavir
This medication has been identified as Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection. It is supplied by Gilead Sciences, Inc.
Sunlenca is used in the treatment of HIV Infection and belongs to the drug class miscellaneous antivirals. Sunlenca 463.5 mg/1.5 mL (309 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Sunlenca
- Generic Name
- lenacapavir
- Strength
- 463.5 mg/1.5 mL (309 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antivirals
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-3002
More about Sunlenca (lenacapavir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Patient resources
- Sunlenca drug information
- Sunlenca oral/injection
- Sunlenca (Lenacapavir Oral) (Advanced Reading)
- Sunlenca (Lenacapavir Subcutaneous) (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
